Department of Surgery, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio; Department of Surgery, Mercy Saint Vincent Medical Center, Toledo, Ohio.
Department of Internal Medicine, Outcomes Research Unit, American University of Beirut, Beirut, Lebanon; Scholars in Health Research Program, American University of Beirut, Beirut, Lebanon.
Ann Thorac Surg. 2018 Jun;105(6):1737-1744. doi: 10.1016/j.athoracsur.2018.01.011. Epub 2018 Feb 2.
Multiarterial coronary grafting with two arterial grafts leads to improved survival compared with conventional single artery based on left internal thoracic artery to left anterior descending artery and saphenous vein grafts. We investigated whether extending arterial grafting to three or more arterial grafts further improves survival, and whether such a benefit is modified by diabetes mellitus.
We analyzed 15-year coronary artery bypass graft surgery mortality data in 11,931 patients (age 64.3 ± 10.5 years; 3,484 women [29.2%]; 4,377 [36.7%] with diabetes mellitus) derived from three US institutions (1994 to 2011). All underwent primary isolated left internal thoracic artery to left anterior descending artery grafting with at least two grafts: one artery (n = 6,782; 56.9%); two arteries (n = 3,678; 30.8%); or three or more arteries (n = 1,471; 12.3%). Long-term survival was estimated by Kaplan-Meier methods. Propensity score matching and comprehensive covariate adjustment (Cox regression) were used to derive long-term risk-adjusted hazard ratio (HR) with 95% confidence interval (CI) for increasing number of arterial grafts in the overall cohort and for diabetes and no-diabetes cohorts.
Radial artery (94%) and right internal thoracic artery (6%) were used as additional arterial grafts. Multivariate analysis in all patients showed that diabetes was associated with decreased survival (HR 1.43, 95% CI: 1.34 to 53), whereas increasing number of arterial grafts was associated with decreased mortality (one artery HR 1.0 [reference]; two arteries HR 0.87, 95% CI: 0.80 to 0.95; and three arteries HR 0.83, 95% CI: 0.72 to 0.95). Pairwise comparisons also showed an incremental benefit of additional arterial grafts: two arteries versus one artery, HR 0.89 (95% CI: 0.80 to 0.98); and three arteries versus one artery, HR 0.80 (95% CI: 0.68 to 0.94). A three-artery versus two-artery survival advantage trend was also noted, but was not significant in either the overall study cohort (HR 0.90, 95% CI: 0.75 to 1.07), the diabetes cohort (HR 0.79, 95% CI: 0.60 to 1.03), or the no-diabetes cohort (HR 01.00, 95% CI: 0.79 to 1.26). Among diabetes patients, the survival advantage of two arteries versus one artery was modest (HR 0.96, 95% CI: 0.72 to 1.11), whereas it was significant for three arteries versus one artery (HR 0.74, 95% CI: 0.58 to 0.96). Analyses of propensity matched subcohorts were also consistent.
Increasing number of arterial grafts improves long-term survival and supports extended use of arterial grafts in coronary artery bypass graft surgery, irrespective of diabetes status.
与传统的左内乳动脉至前降支和大隐静脉搭桥相比,采用两条以上动脉搭桥可提高生存率。我们研究了增加到三条或更多动脉搭桥是否进一步改善了生存率,以及这种益处是否受糖尿病的影响。
我们分析了来自美国三家机构的 11931 名患者(年龄 64.3±10.5 岁;3484 名女性[29.2%];4377 名[36.7%]患有糖尿病)在 15 年的冠状动脉旁路移植术死亡率数据(1994 年至 2011 年)。所有患者均接受了初次单纯左内乳动脉至前降支搭桥术,至少有两条搭桥:一条动脉(n=6782;56.9%);两条动脉(n=3678;30.8%);或三条或更多动脉(n=1471;12.3%)。采用 Kaplan-Meier 法估计长期生存率。采用倾向评分匹配和综合协变量调整(Cox 回归),在总体队列和糖尿病及非糖尿病队列中,得出增加动脉搭桥数量与长期风险调整后的危险比(HR)及其 95%置信区间(CI)。
桡动脉(94%)和右内乳动脉(6%)被用作额外的动脉搭桥。多变量分析显示,糖尿病与生存率降低相关(HR 1.43,95%CI:1.34至 53),而增加动脉搭桥数量与死亡率降低相关(一条动脉 HR 1.0[参考];两条动脉 HR 0.87,95%CI:0.80 至 0.95;三条动脉 HR 0.83,95%CI:0.72 至 0.95)。两两比较还显示了额外动脉搭桥的获益递增:两条动脉与一条动脉相比,HR 0.89(95%CI:0.80 至 0.98);三条动脉与一条动脉相比,HR 0.80(95%CI:0.68 至 0.94)。还观察到了三条动脉与两条动脉生存优势的趋势,但在总体研究队列中(HR 0.90,95%CI:0.75 至 1.07)、糖尿病队列(HR 0.79,95%CI:0.60 至 1.03)或非糖尿病队列(HR 01.00,95%CI:0.79 至 1.26)中均无统计学意义。在糖尿病患者中,两条动脉与一条动脉的生存优势相对较小(HR 0.96,95%CI:0.72 至 1.11),而三条动脉与一条动脉的生存优势显著(HR 0.74,95%CI:0.58 至 0.96)。倾向性匹配亚组的分析结果也一致。
增加动脉搭桥数量可提高长期生存率,并支持在冠状动脉旁路移植术中更广泛地使用动脉搭桥,无论糖尿病状况如何。